This Article Full Text Full Text (PDF) All Versions of this Article: 108/1/97    most recent 01.CIR.0000079100.38176.83v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lu, E. Articles by Villanueva, F. S. Search for Related Content PubMed PubMed Citation Articles by Lu, E. Articles by Villanueva, F. S. Pubmed/NCBI databases Substance via MeSH Related Collections Peripheral vascular disease Pacemaker Cardiovascular imaging agents/Techniques Ischemic biology - basic studies

(Circulation. 2003;108:97.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Targeted In Vivo Labeling of Receptors for Vascular Endothelial Growth Factor

Approach to Identification of Ischemic Tissue

Erxiong Lu, MD; William R. Wagner, PhD; Ute Schellenberger, PhD; Judith A. Abraham, PhD; Alexander L. Klibanov, PhD; Steven R. Woulfe, PhD; Melissa M. Csikari, BS; David Fischer, BS; George F. Schreiner, MD; Gary H. Brandenburger, PhD; Flordeliza S. Villanueva, MD

From the University of Pittsburgh (E.L., W.R.W., M.M.C., D.F., F.S.V.), Cardiovascular Institute and Department of Bioengineering, Pittsburgh, Pa; Scios Inc (U.S., J.A.A., G.F.S.), Sunnyvale, Calif; and Mallinckrodt Inc (A.L.K., S.R.W., G.H.B.), St Louis, Mo.

Reprint requests to Flordeliza S. Villanueva, MD, University of Pittsburgh, Cardiovascular Institute, 200 Lothrop St, S568 Scaife Hall, Pittsburgh, PA 15213. E-mail villanuevafs{at}msx.upmc.edu

Background— A method for identifying tissue experiencing hypoxic stress due to atherosclerotic vascular disease would be clinically useful. Vascular endothelial growth factor-121 (VEGF₁₂₁) is an angiogenic protein secreted in response to hypoxia that binds to VEGF receptors overexpressed by ischemic microvasculature. We tested the hypothesis that VEGF receptors could serve as markers for ischemic tissue and hence provide a target for imaging such tissue with radiolabeled human VEGF₁₂₁.

Methods and Results— A rabbit model of unilateral hindlimb ischemia was created by femoral artery excision (n=14). Control rabbits (n=5) underwent identical surgery without femoral excision. On postoperative day 10, rabbits were intravenously administered 100 µCi of ¹¹¹In-labeled recombinant human VEGF₁₂₁, and biodistribution studies and planar imaging were conducted at 3, 24, and 48 hours. On postmortem gamma counting, there was greater accumulation of ¹¹¹In-labeled VEGF₁₂₁ in ischemic than in control tissue (P<0.02). Differential uptake of isotope by ischemic muscle was not seen in rabbits injected with ¹²⁵I-labeled human serum albumin (n=6). Radioactivity imaged in hindlimb regions of interest was significantly higher in ischemic muscle than in sham-operated and contralateral nonoperated hindlimb at 3 hours (P<0.02). Immunohistochemical staining confirmed upregulation of VEGF receptors in ischemic skeletal muscle.

Conclusions— Identification of the ischemic state via targeted radiolabeling of hypoxia-induced angiogenic receptors is possible. This approach could be useful for monitoring the efficacy of revascularization strategies such as therapeutic angiogenesis.

Key Words: angiogenesis • hypoxia • imaging • isotopes • receptors

This article has been cited by other articles:

				T. H. Marwick and M. Schwaiger The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools Circ Cardiovasc Imaging, July 1, 2008; 1(1): 58 - 69. [Full Text] [PDF]

				M. Rodriguez-Porcel, W. Cai, O. Gheysens, J. K. Willmann, K. Chen, H. Wang, I. Y. Chen, L. He, J. C. Wu, Z.-b. Li, et al. Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET J. Nucl. Med., April 1, 2008; 49(4): 667 - 673. [Abstract] [Full Text] [PDF]

				J. K. Willmann, K. Chen, H. Wang, R. Paulmurugan, M. Rollins, W. Cai, D. S. Wang, I. Y. Chen, O. Gheysens, M. Rodriguez-Porcel, et al. Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography Circulation, February 19, 2008; 117(7): 915 - 922. [Abstract] [Full Text] [PDF]

				W. Cai, K. Chen, K. A. Mohamedali, Q. Cao, S. S. Gambhir, M. G. Rosenblum, and X. Chen PET of Vascular Endothelial Growth Factor Receptor Expression J. Nucl. Med., December 1, 2006; 47(12): 2048 - 2056. [Abstract] [Full Text] [PDF]

				W. Cai, J. Rao, S. S. Gambhir, and X. Chen How molecular imaging is speeding up antiangiogenic drug development. Mol. Cancer Ther., November 1, 2006; 5(11): 2624 - 2633. [Abstract] [Full Text] [PDF]

				C. Chan, J. Sandhu, A. Guha, D. A. Scollard, J. Wang, P. Chen, K. Bai, L. Lee, and R. M. Reilly A Human Transferrin-Vascular Endothelial Growth Factor (hnTf-VEGF) Fusion Protein Containing an Integrated Binding Site for 111In for Imaging Tumor Angiogenesis J. Nucl. Med., October 1, 2005; 46(10): 1745 - 1752. [Abstract] [Full Text] [PDF]

				F. S. Villanueva Molecular Images of Neovascularization: Art for Art's Sake or Form With a Function? Circulation, June 21, 2005; 111(24): 3188 - 3191. [Full Text] [PDF]

				M. Simons Angiogenesis: Where Do We Stand Now? Circulation, March 29, 2005; 111(12): 1556 - 1566. [Full Text] [PDF]

				S. Maschauer, O. Prante, M. Hoffmann, J. T. Deichen, and T. Kuwert Characterization of 18F-FDG Uptake in Human Endothelial Cells In Vitro J. Nucl. Med., March 1, 2004; 45(3): 455 - 460. [Abstract] [Full Text]